Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SHYF
|
Joshua A Sherbin
Chief Administration Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,131 Added 18.45% |
-
|
Mar 31
2022 |
|
CSV
|
Douglas B. Meehan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 656 Added 3.43% |
$34,984
$53.33 p/Share
|
Mar 31
2022 |
|
CSV
|
Greg M Brudnicki |
BUY
Grant, award, or other acquisition
|
Direct | 93 Added 0.35% |
$4,960
$53.33 p/Share
|
Mar 31
2022 |
|
CSV
|
Achille Messac
Director |
BUY
Grant, award, or other acquisition
|
Direct | 679 Added 7.75% |
$36,211
$53.33 p/Share
|
Mar 31
2022 |
|
CSV
|
Bryan Leibman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 468 Added 1.3% |
$24,958
$53.33 p/Share
|
Mar 31
2022 |
|
CSV
|
Barry K Fingerhut
Director |
BUY
Grant, award, or other acquisition
|
Direct | 679 Added 2.63% |
$36,211
$53.33 p/Share
|
Mar 31
2022 |
|
CSV
|
Donald Douglas Patteson Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 187 Added 0.3% |
$9,973
$53.33 p/Share
|
Mar 31
2022 |
|
CDE
|
Hans John Rasmussen
SVP, Exploration |
SELL
Payment of exercise price or tax liability
|
Direct | 13,656 Reduced 4.14% |
$60,769
$4.45 p/Share
|
Mar 31
2022 |
|
ARMP
|
Innoviva, Inc.
Director |
BUY
Open market or private purchase
|
Indirect | 5,385,208 Added 24.76% |
$26,926,040
$5.0 p/Share
|
Mar 31
2022 |
|
FGEN
|
Mark Eisner
EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,442 Reduced 4.09% |
$77,433
$12.02 p/Share
|
Mar 31
2022 |
|
FGEN
|
Christine Chung
SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct | 4,682 Reduced 1.87% |
$56,278
$12.02 p/Share
|
Mar 31
2022 |
|
CMP
|
Joseph E Reece
Director |
BUY
Grant, award, or other acquisition
|
Direct | 687 Added 5.34% |
-
|
Mar 31
2022 |
|
CMP
|
Edward C Dowling
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 18 Added 50.0% |
-
|
Mar 31
2022 |
|
LPI
|
M. Jason Pigott
President & CEO |
SELL
Open market or private sale
|
Direct | 5,531 Reduced 4.23% |
$452,878
$81.88 p/Share
|
Mar 31
2022 |
|
ADUS
|
Roberton James Stevenson
EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct | 72 Reduced 1.18% |
$6,535
$90.77 p/Share
|
Mar 31
2022 |
|
RXT
|
Mitchell Alan Garber
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,778 Added 13.06% |
-
|
Mar 31
2022 |
|
VGR
|
Ronald J Bernstein |
BUY
Open market or private sale
|
Direct | 10,000 Added 12.1% |
$123,200
$12.32 p/Share
|
Mar 31
2022 |
|
NG
|
Gregory A. Lang
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 2,175 Added 46.15% |
$15,116
$6.95 p/Share
|
Mar 31
2022 |
|
NG
|
David A. Ottewell
Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 1,197 Added 0.15% |
$8,319
$6.95 p/Share
|
Mar 31
2022 |
|
GTN
|
Harriett J Robinson
> 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect | 135,795 Added 17.82% |
$3,062,177
$22.55 p/Share
|
Mar 31
2022 |
|
GTN
|
Harriett J Robinson
> 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 135,795 Reduced 100.0% |
$3,062,177
$22.55 p/Share
|
Mar 31
2022 |
|
GTN
|
Harriett J Robinson
> 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 10,000 Reduced 100.0% |
$247,500
$24.75 p/Share
|
Mar 31
2022 |
|
KTOS
|
Steven S. Fendley
President, US Division |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 2.12% |
$144,130
$20.59 p/Share
|
Mar 31
2022 |
|
EXPI
|
Eugene Frederick |
BUY
Grant, award, or other acquisition
|
Indirect | 38 Added 0.17% |
-
|
Mar 31
2022 |
|
EXPI
|
Eugene Frederick |
BUY
Grant, award, or other acquisition
|
Direct | 110 Added 0.0% |
-
|
Mar 31
2022 |
|
NOG
|
Robert Grabb
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,197 Added 2.1% |
-
|
Mar 31
2022 |
|
NOG
|
Roy Ernest Easley
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,197 Added 2.85% |
-
|
Mar 31
2022 |
|
NOG
|
Stuart G. Lasher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,197 Added 2.61% |
-
|
Mar 31
2022 |
|
NOG
|
Michael T Popejoy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,197 Added 3.22% |
-
|
Mar 31
2022 |
|
NOG
|
Lisa Meier
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,197 Added 3.01% |
-
|
Mar 31
2022 |
|
NOG
|
Jack E King
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,197 Added 2.22% |
-
|
Mar 31
2022 |
|
NOG
|
Bahram Akradi
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,075 Added 0.35% |
-
|
Mar 31
2022 |
|
NOG
|
Jennifer S. Pomerantz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,197 Added 50.0% |
-
|
Mar 31
2022 |
|
NOG
|
Michael A Frantz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,197 Added 2.66% |
-
|
Mar 31
2022 |
|
BANR
|
Peter Conner
Exec Consultant, Banner Bank |
BUY
Grant, award, or other acquisition
|
Direct | 7,042 Added 13.2% |
$412,168
$58.53 p/Share
|
Mar 31
2022 |
|
BANR
|
Janet M Brown
Executive VP, Banner Bank |
BUY
Grant, award, or other acquisition
|
Direct | 3,752 Added 33.86% |
$219,605
$58.53 p/Share
|
Mar 31
2022 |
|
BANR
|
James M Costa
Executive VP, Banner Bank |
BUY
Grant, award, or other acquisition
|
Direct | 6,837 Added 42.11% |
$400,170
$58.53 p/Share
|
Mar 31
2022 |
|
BANR
|
Mark J Grescovich
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 23,806 Added 10.94% |
$1,393,365
$58.53 p/Share
|
Mar 31
2022 |
|
BANR
|
Kenneth William Johnson
Executive VP, Banner Bank |
BUY
Grant, award, or other acquisition
|
Direct | 2,210 Added 9.16% |
$129,351
$58.53 p/Share
|
Mar 31
2022 |
|
BANR
|
Kayleen R Kohler
Executive VP, Banner Bank |
BUY
Grant, award, or other acquisition
|
Direct | 3,515 Added 17.54% |
$205,733
$58.53 p/Share
|
Mar 31
2022 |
|
BANR
|
Kenneth A Larsen
Executive VP, Banner Bank |
BUY
Grant, award, or other acquisition
|
Direct | 2,762 Added 13.24% |
$161,660
$58.53 p/Share
|
Mar 31
2022 |
|
BANR
|
James P.G. Mc Lean
Executive VP, Banner Bank |
BUY
Grant, award, or other acquisition
|
Direct | 3,622 Added 15.79% |
$211,996
$58.53 p/Share
|
Mar 31
2022 |
|
KAI
|
Eric T Langevin
Executive Vice President & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 834 Reduced 2.47% |
$162,889
$195.31 p/Share
|
Mar 31
2022 |
|
KAI
|
Eric T Langevin
Executive Vice President & COO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,880 Added 5.37% |
-
|
Mar 31
2022 |
|
ALHC
|
Richard A. Cross
SVP, General Counsel |
SELL
Open market or private sale
|
Direct | 1,592 Reduced 0.53% |
$17,799
$11.18 p/Share
|
Mar 31
2022 |
|
ALHC
|
Donald Steven Furman
Chief Clinical Officer |
SELL
Open market or private sale
|
Direct | 3,006 Reduced 0.16% |
$33,607
$11.18 p/Share
|
Mar 31
2022 |
|
ALHC
|
John E Kao
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 26,366 Reduced 3.26% |
$294,772
$11.18 p/Share
|
Mar 31
2022 |
|
ALHC
|
Dinesh M. Kumar
Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct | 3,058 Reduced 0.26% |
$34,188
$11.18 p/Share
|
Mar 31
2022 |
|
ALHC
|
Robert Thomas Freeman
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,944 Reduced 1.18% |
$55,274
$11.18 p/Share
|
Mar 31
2022 |
|
ALHC
|
Dawn Christine Maroney
President |
SELL
Open market or private sale
|
Direct | 6,681 Reduced 0.39% |
$74,694
$11.18 p/Share
|
Mar 31
2022 |